The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
Abstract
Purpose: The panel updated the American Society of Clinical Oncology (ASCO) adjuvant therapy guideline for resected non–small-cell lung cancers. Methods: ASCO convened an update panel and conducted a systematic review of the literature, investigating adjuvant therapy in resected non–small-cell lung cancers. Results: The updated evidence base covered questions related to adjuvant systemic therapy and included a systematic review conducted by Cancer Care Ontario current to January 2016. A recent American Society for Radiation Oncology guideline and systematic review, previously endorsed by ASCO, was used as the basis for recommendations for adjuvant radiation therapy. An update of these systematic reviews and a search for studies related to radiation therapy found no additional randomized controlled trials. Recommendations: Adjuvant cisplatin-based chemotherapy is recommended for routine use in patients with stage IIA, IIB, or IIIA disease who have undergone complete surgical resections. For individuals with stage IB, adjuvant cisplatin-based chemotherapy is not recommended for routine use. However, a postoperative multimodality evaluation, including a consultation with a medical oncologist, is recommended to assess benefits and risks of adjuvant chemotherapy for each patient. The guideline provides information on factors other than stage to consider when making a recommendation for adjuvant chemotherapy, including tumor size, histopathologic features, and genetic alterations. Adjuvant chemotherapy is not recommended for patients with stage IA disease. Adjuvant radiation therapy is not recommended for patients with resected stage I or II disease. In patients with stage IIIA N2 disease, adjuvant radiation therapy is not recommended for routine use. However, a postoperative multimodality evaluation, including a consultation with a radiation oncologist, is recommended to assess benefits and risks of adjuvant radiation therapy for each patient with N2 disease. Additional information is available at www.asco.org/lung-cancer-guidelines and www.asco.org/guidelineswiki .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Non-small Cell Lung Cancer Collaborative Group (1995) · BMJ · doi:10.1136/bmj.311.7010.899 · Cited by 2,850
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Pignon, J.-P., Tribodet, H., Scagliotti, G. V., Douillard, J.-Y., Shepherd, F. A., Stephens, R. J., Dunant, A., Torri, V., Rosell, R., Seymour, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9030 · Cited by 2,642
Self-citationGene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
Winton, T., Livingston, R., Johnson, D., Rigas, J., Johnston, M., Butts, C., Cormier, Y., Goss, G., Inculet, R., Vallieres, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043623 · Cited by 1,810
Self-citationDNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., André, F., Haddad, V., Taranchon, E., Filipits, M., Pirker, R., Popper, H. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060570 · Cited by 1,727
Postmus, P. E., Brambilla, E., Chansky, K., Crowley, J., Goldstraw, P., Patz, E. F., & Yokomise, H. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31811f4703 · Cited by 1,594
Yoshizawa, A., Motoi, N., Riely, G. J., Sima, C. S., Gerald, W. L., Kris, M. G., Park, B. J., Rusch, V. W., & Travis, W. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.232 · Cited by 976
Self-citationStrauss, G. M., Herndon, J. E., Maddaus, M. A., Johnstone, D. W., Johnson, E. A., Harpole, D. H., Gillenwater, H. H., Watson, D. M., Sugarbaker, D. J., Schilsky, R. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4855 · Cited by 974
How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis
Shojania, K. G., Sampson, M., Ansari, M. T., Ji, J., Doucette, S., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00179 · Cited by 838
Stigma, shame, and blame experienced by patients with lung cancer: qualitative study
Chapple, A., Ziebland, S., & McPherson, A. (2004) · BMJ · doi:10.1136/bmj.38111.639734.7c · Cited by 789
Rami-Porta, R., Bolejack, V., Crowley, J., Ball, D., Kim, J., Lyons, G., Rice, T., Suzuki, K., Thomas, C. F., Travis, W. D., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000559 · Cited by 758
Warth, A., Muley, T., Meister, M., Stenzinger, A., Thomas, M., Schirmacher, P., Schnabel, P. A., Budczies, J., Hoffmann, H., & Weichert, W. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2185 · Cited by 692
Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer
Olivotto, I. A., Bajdik, C. D., Ravdin, P. M., Speers, C. H., Coldman, A. J., Norris, B. D., Davis, G. J., Chia, S. K., & Gelmon, K. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.178 · Cited by 567
Vansteenkiste, J. F., Cho, B. C., Vanakesa, T., De Pas, T., Zielinski, M., Kim, M. S., Jassem, J., Yoshimura, M., Dahabreh, J., Nakayama, H., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00099-1 · Cited by 511
Kelly, K., Altorki, N. K., Eberhardt, W. E. E., O'Brien, M. E. R., Spigel, D. R., Crinò, L., Tsai, C.-M., Kim, J.-H., Cho, E. K., Hoffman, P. C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.8918 · Cited by 480
Self-citationZhu, C.-Q., Ding, K., Strumpf, D., Weir, B. A., Meyerson, M., Pennell, N., Thomas, R. K., Naoki, K., Ladd-Acosta, C., Liu, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4325 · Cited by 471
Self-citationLally, B. E., Zelterman, D., Colasanto, J. M., Haffty, B. G., Detterbeck, F. C., & Wilson, L. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6110 · Cited by 469
Yoshizawa, A., Sumiyoshi, S., Sonobe, M., Kobayashi, M., Fujimoto, M., Kawakami, F., Tsuruyama, T., Travis, W. D., Date, H., & Haga, H. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182769aa8 · Cited by 436
Felip, E., Rosell, R., Maestre, J. A., Rodríguez-Paniagua, J. M., Morán, T., Astudillo, J., Alonso, G., Borro, J. M., González-Larriba, J. L., Torres, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6204 · Cited by 430
Butts, C. A., Ding, K., Seymour, L., Twumasi-Ankrah, P., Graham, B., Gandara, D., Johnson, D. H., Kesler, K. A., Green, M., Vincent, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.0333 · Cited by 425
Self-citationArriagada, R., Dunant, A., Pignon, J.-P., Bergman, B., Chabowski, M., Grunenwald, D., Kozlowski, M., Le Péchoux, C., Pirker, R., Pinel, M.-I. S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2272 · Cited by 394
Breaking Bad News About Cancer: Patients’ Preferences for Communication
Parker, P. A., Baile, W. F., de Moor, C., Lenzi, R., Kudelka, A. P., & Cohen, L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.7.2049 · Cited by 388
Pisters, K. M. W., Evans, W. K., Azzoli, C. G., Kris, M. G., Smith, C. A., Desch, C. E., Somerfield, M. R., Brouwers, M. C., Darling, G., Ellis, P. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1226 · Cited by 363
Self-citationGoss, G. D., O'Callaghan, C., Lorimer, I., Tsao, M.-S., Masters, G. A., Jett, J., Edelman, M. J., Lilenbaum, R., Choy, H., Khuri, F., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.1816 · Cited by 356
Self-citationWhat Happens to Patients Undergoing Lung Cancer Surgery?
Handy, J. R., Asaph, J. W., Skokan, L., Reed, C. E., Koh, S., Brooks, G., Douville, E. C., Tsen, A. C., Ott, G. Y., & Silvestri, G. A. (2002) · Chest · doi:10.1378/chest.122.1.21 · Cited by 308
Shepherd, F. A., Domerg, C., Hainaut, P., Jänne, P. A., Pignon, J.-P., Graziano, S., Douillard, J.-Y., Brambilla, E., Le Chevalier, T., Seymour, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.1390 · Cited by 293
Self-citationTsao, M.-S., Marguet, S., Le Teuff, G., Lantuejoul, S., Shepherd, F. A., Seymour, L., Kratzke, R., Graziano, S. L., Popper, H. H., Rosell, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8335 · Cited by 267
Self-citationHung, J.-J., Yeh, Y.-C., Jeng, W.-J., Wu, K.-J., Huang, B.-S., Wu, Y.-C., Chou, T.-Y., & Hsu, W.-H. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.1049 · Cited by 256
Douillard, J.-Y., Tribodet, H., Aubert, D., Shepherd, F. A., Rosell, R., Ding, K., Veillard, A.-S., Seymour, L., Le Chevalier, T., Spiro, S., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c814e7 · Cited by 252
Self-citationRobinson, C. G., Patel, A. P., Bradley, J. D., DeWees, T., Waqar, S. N., Morgensztern, D., Baggstrom, M. Q., Govindan, R., Bell, J. M., Guthrie, T. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.5380 · Cited by 244
(2008) · Cited by 225
Ujiie, H., Kadota, K., Chaft, J. E., Buitrago, D., Sima, C. S., Lee, M.-C., Huang, J., Travis, W. D., Rizk, N. P., Rudin, C. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.9818 · Cited by 225
Self-citationShiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
Reynolds, C., Obasaju, C., Schell, M. J., Li, X., Zheng, Z., Boulware, D., Caton, J. R., DeMarco, L. C., O'Rourke, M. A., Shaw Wright, G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9766 · Cited by 172
Patients’ Perceptions of Receiving Bad News About Cancer
Ptacek, J. T., & Ptacek, J. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.21.4160 · Cited by 168
Bezjak, A., Temin, S., Franklin, G., Giaccone, G., Govindan, R., Johnson, M. L., Rimner, A., Schneider, B. J., Strawn, J., & Azzoli, C. G. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.2360 · Cited by 168
Self-citationDo doctors know when their patients don't?
Quirt, C. F., Mackillop, W. J., Ginsburg, A. D., Sheldon, L., Brundage, M., Dixon, P., & Ginsburg, L. (1997) · Lung Cancer · doi:10.1016/s0169-5002(97)00048-2 · Cited by 163
Billiet, C., Decaluwé, H., Peeters, S., Vansteenkiste, J., Dooms, C., Haustermans, K. M., Leyn, P. D., & Ruysscher, D. D. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.08.011 · Cited by 152
Bepler, G., Williams, C. C., Schell, M. J., Chen, W., Zheng, Z., Simon, G. R., Gadgeel, S. M., Zhao, X., Schreiber, F. J., Brahmer, J. R., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9783 · Cited by 141
Uchitomi, Y., Mikami, I., Nagai, K., Nishiwaki, Y., Akechi, T., & Okamura, H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.139 · Cited by 139
Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art.
Artal, A., Calera, L., & Cubero, J. H. (2015) · PubMed · doi:10.3978/j.issn.2218-6751.2014.06.01 · Cited by 127
Wistuba, I. I., Behrens, C., Lombardi, F., Wagner, S., Fujimoto, J., Raso, M. G., Spaggiari, L., Galetta, D., Riley, R., Hughes, E., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0596 · Cited by 113
Rodrigues, G., Choy, H., Bradley, J. D., Rosenzweig, K. E., Bogart, J. A., Curran, W. J., Gore, E., Langer, C. J., Louie, A. V., Lutz, S., et al. (2015) · Practical Radiation Oncology · doi:10.1016/j.prro.2015.02.013 · Cited by 110
Corso, C. D., Rutter, C. E., Wilson, L. D., Kim, A. W., Decker, R. H., & Husain, Z. A. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000406 · Cited by 104
Mansuet‐Lupo, A., Bobbio, A., Blons, H., Becht, É., Ouakrim, H., Didelot, A., Charpentier, M.-C., Bain, S., Marmey, B., Bonjour, P., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2499 · Cited by 97
Gentles, A. J., Bratman, S. V., Lee, L. J., Harris, J. P., Feng, W., Nair, R. V., Shultz, D. B., Nair, V. S., Hoang, C. D., West, R. B., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv211 · Cited by 92
Discussing Adjuvant Cancer Therapy
Leighl, N. B., Gattellari, M., Butow, P. N., Brown, R., & Tattersall, M. H. N. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1768 · Cited by 89
Chao, C., Studts, J. L., Abell, T. D., Hadley, T. J., Roetzer, L. M., Dineen, S. P., Lorenz, D., YoussefAgha, A. H., & McMasters, K. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.025 · Cited by 88
Setting Goals to Maintain Hope
Roenn, J. H. V., & von Gunten, C. F. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.161 · Cited by 63
Huang, Q., Li, J., Sun, Y., Wang, R., Cheng, X., & Chen, H. (2015) · CHEST Journal · doi:10.1016/j.chest.2015.12.017 · Cited by 52
Bueno, R., Hughes, E., Wagner, S., Gutin, A., Lanchbury, J. S. S., Zheng, Y., Archer, M. A., Gustafson, C. E., Jones, J. T., Rushton, K., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000365 · Cited by 46
Fibla, J. J., Cassivi, S. D., Brunelli, A., Decker, P. A., Allen, M. S., Darling, G. E., Landreneau, R. J., & Putnam, J. B. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.09.010 · Cited by 45
Patel, S. H., Ma, Y., Wernicke, A. G., Nori, D., Chao, K. S. C., & Parashar, B. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.02.016 · Cited by 45
(2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.154 · Cited by 43
Prognostic impact of vascular and lymphovascular invasion in early lung cancer
Al-Alao, B. S., Gately, K. A., Nicholson, S. A., McGovern, E. M., Young, V., & O'Byrne, K. J. (2013) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492313478431 · Cited by 41
Stewart, L. A., Burdett, S., Tierney, J. F., & Pignon, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.7552 · Cited by 40
Burdett, S., Rydzewska, L. H. M., Tierney, J. F., & Fisher, D. J. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.02.005 · Cited by 38
Cuffe, S. D., Bourredjem, A., Graziano, S. L., Pignon, J., Domerg, C., Ezzalfani, M., Seymour, L., Strevel, E. L., Burkes, R. L., Capelletti, M., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824fe9e6 · Cited by 31
Self-citationLymphatic invasion predicts survival in patients with early node-negative non–small cell lung cancer
Nentwich, M. F., Bohn, B. A., Uzunoglu, F. G., Reeh, M., Quaas, A., Grob, T. J., Perez, D. R., Kutup, A., Bockhorn, M., Izbicki, J. R., et al. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.04.037 · Cited by 29
Adjuvant Carboplatin-based Chemotherapy in Resected Stage IIIA-N2 Non-small Cell Lung Cancer
Ou, W., Sun, H.-B., Xiong, Y., Zhang, B.-B., Yang, H., Fang, Q., Li, P., & Wang, S. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d95db4 · Cited by 29
Novello, S. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.7587 · Cited by 18
Bepler, G., Zinner, R., Moon, J., Calhoun, R. F., Kernstine, K. H., Williams, C. C., Mack, P. C., Oliveira, V. A., Zheng, Z., Stella, P. J., et al. (2014) · Cancer · doi:10.1002/cncr.28714 · Cited by 11
Cited by
The biology and management of non-small cell lung cancer
Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891
Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
Wu, Y.-L., Tsuboi, M., He, J., John, T., Grohe, C., Majem, M., Goldman, J. W., Laktionov, K., Kim, S.-W., Kato, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2027071 · Cited by 1,798
Self-citationOverall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
Tsuboi, M., Herbst, R. S., John, T., Kato, T., Majem, M., Grohé, C., Wang, J., Goldman, J. W., Lu, S., Su, W.-C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2304594 · Cited by 672
Self-citationZhong, W.-Z., Wang, Q., Mao, W.-M., Xu, S.-T., Wu, L., Shen, Y., Liu, Y.-Y., Chen, C., Cheng, Y., Xu, L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30729-5 · Cited by 529
Herbst, R. S., Wu, Y.-L., John, T., Grohe, C., Majem, M., Wang, J., Kato, T., Goldman, J. W., Laktionov, K., Kim, S.-W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02186 · Cited by 408
Self-citation
Metadata
- Authors
- Kris, M. G., Gaspar, L. E., Chaft, J. E., Kennedy, E. B., Azzoli, C. G., Ellis, P. M., Lin, S. H., Pass, H. I., Seth, R., Shepherd, F. A., Spigel, D. R., Strawn, J. R., Ung, Y. C., & Weyant, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2017-09-01
- Volume
- 35
- Issue
- 25
- Pages
- 2960-2974
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2607970143
- Cited by
- 368
- References
- 66
- FWCI
- 19.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.